Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 35c, Revenues Beat; Offers FY20 Revenue Outlook Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. AXP
6. T
7. TMUS
8. UNH
9. BRO
10. DAL

Go back to Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 35c, Revenues Beat; Offers FY20 Revenue Outlook Below Consensus

Akcea Therapeutics to Present at the Cowen 40th Annual Health Care Conference

February 26, 2020 7:01 AM EST

BOSTON, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious and rare diseases, today announced that Damien McDevitt, Interim CEO, will present at the Cowen 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020 at 10:40 a.m. ET.

The above listed date is subject to change. Details on presentation times or changes to presentation dates can be found on the Companys website. Please check... More